About Direxion Daily S&P Biotech Bear 3X Shares (LABD)

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. LABD is designed for investors who seek to profit from the potential downside of the biotechnology sector. The fund employs a strategy called "shorting" to achieve its investment objective. Shorting involves borrowing shares, selling them, and buying them back later to return to the lender, with the hope that the share price will decrease during this time. LABD seeks to magnify the inverse daily performance of the index, meaning that if the index declines by 1%, LABD aims to increase by 3%, and vice versa.

The price history of LABD reflects its objective of providing daily inverse 3x exposure to the S&P Biotechnology Select Industry Index. As the index experiences fluctuations, the price of LABD will also fluctuate accordingly. It should be noted that due to the daily compounding effect of the ETF's investment strategy, the performance of LABD over periods longer than a day may deviate significantly from the inverse of the index. As a leveraged ETF, LABD is intended for short-term trading and may not be suitable for all investors. It is important for individuals considering LABD to carefully read the prospectus and understand the risks before investing.